Notch1 O-GlcNAcylation drives tumor stemness and mechanoadaptation to a stiff microenvironment and promotes chordoma recurrence
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci194378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Chengjie Lian und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing …. Hauptthemen laut MEDLINE: Tumor Microenvironment, Receptor, Notch1, Neoplastic Stem Cells, Chordoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing Science and Technology Commission, Chongqing High-Level Medical Talent Program for Young and Middle-Aged Individuals.
Abstract (Originalsprache)
Chordomas are rare malignant osseous neoplasms with a striking rate of recurrence. Primary chordomas typically originate from embryonic notochord remnants, whereas recurrent chordomas usually stem from tumor cells infiltrating bone or cartilage after surgery. Clinically, the recurrent chordomas exhibit a stiffer extracellular microenvironment (ECM) than primary tumors. Intriguingly, this study identified cytoskeleton rearrangement, stress fiber reorganization, enhanced stemness, and Notch signaling activation in recurrent chordoma tissues or cell lines surviving stiff substrates, indicating the critical roles of mechanical remodeling and tumor stemness in stiffness resistance. We propose a potentially novel recurrence model where tumor cells experience mechanoadaptive organization, which enables them to resist stiff microenvironment-induced cell death. O-GlcNAcylation of Notch1 intracellular domain (NICD1) is central to this process. Mechanistically, the stiff ECM-driven ligand-independent phosphorylation of EPHA2 sequentially activated LYN kinase and subsequently triggered O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) activity by phosphorylating Y989 and Y418, critical residues for OGT glycosyltransferase activity; this induced NICD1 O-GlcNAcylation at T2063, T2090, and S2162, specifically promoting transcription of mechanical and stemness-related genes. MIR31 deletion upregulated LYN, enhancing stiffness perception and promoting O-GlcNAc addition to NICD1, finally resulting in mechanoadaptation- and tumor stemness–driven recurrence. Consequently, MIR31 deletion is a potential biomarker for recurrence and patient stratification in Notch- or OGT-targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast and Thyroid Surgery, Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Orthopaedics, Sports Injury Division, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
- Department of Orthopedics and.
- Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
- Department of Spine Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Department of Biology, School of Basic Medical Science, Guangdong Medical University, Zhanjiang, Guangdong, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing Science and Technology Commission
- Chongqing High-Level Medical Talent Program for Young and Middle-Aged Individuals
- Chongqing Science and Technology Bureau and Health Commission Joint Fund
- The Science and Technology Research Project of Chongqing Education Commission
- Fujian Provincial Natural Science Foundation of China
- Research project of Fujian Medical University Union Hospital
- Joint Funds for the innovation of Science and Technology, Fujian province
Zitieren
APA
Lian, C., Peng, W., Su, P., Ye, Y., Liu, J., Huang, D., Sun, X., Pu, Y., Liao, Z., Wang, X., Qiu, Z., Wu, S., & Liu, L. (2026). Notch1 O-GlcNAcylation drives tumor stemness and mechanoadaptation to a stiff microenvironment and promotes chordoma recurrence. Journal of Clinical Investigation. https://doi.org/10.1172/jci194378
Vancouver
Lian C, Peng W, Su P, Ye Y, Liu J, Huang D, et al. Notch1 O-GlcNAcylation drives tumor stemness and mechanoadaptation to a stiff microenvironment and promotes chordoma recurrence. Journal of Clinical Investigation. 2026. doi:10.1172/jci194378
BibTeX
@article{Lian2026,
author = {Lian, Chengjie and Peng, Weiyan and Su, Peiqiang and Ye, Yan and Liu, Jialing and Huang, Dongsheng and Sun, Xuejuan and Pu, Yi and Liao, Zhiheng and Wang, Xudong and Qiu, Zhu and Wu, Shanshan and Liu, Lei},
title = {Notch1 O-GlcNAcylation drives tumor stemness and mechanoadaptation to a stiff microenvironment and promotes chordoma recurrence},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci194378}
}
EUVIMED